In one of her final acts as Director of National Intelligence (DNI) under President Donald Trump, Tulsi Gabbard dropped a major declassification on June 12, 2026, revealing longstanding U.S. government funding for more than 120 biological laboratories across over 30 countries, including facilities in Ukraine.
The announcement, coming just weeks before her resignation effective June 30, has sparked intense discussion about government transparency, pandemic risks, and international security implications.
What Gabbard Revealed
According to the Office of the Director of National Intelligence (ODNI), the declassified materials detail U.S. taxpayer support—primarily through programs like the Pentagon’s Biological Threat Reduction Program—for labs researching biological pathogens, some hazardous. Gabbard highlighted risks in Ukraine amid the ongoing war, noting prior intelligence warnings about vulnerable facilities housing dangerous pathogens.
She tied the release to President Trump’s May 2025 Executive Order aimed at ending federal funding for “dangerous Gain-of-Function (GoF) research” worldwide. GoF research involves modifying pathogens to study transmissibility or virulence, which proponents argue aids preparedness, but critics warn can create pandemic risks.
Gabbard accused Biden-era officials, including Dr. Anthony Fauci, of misleading the public and suppressing discussion. The move aligns with broader Trump administration efforts for greater oversight and transparency in overseas biological research.
Context of the Resignation
Gabbard announced her resignation in late May 2026, citing her husband Abraham Williams’ diagnosis with an extremely rare form of bone cancer. She emphasized the need to support her family during this challenging time. President Trump publicly praised her service.
The timing of the biolabs disclosure—shortly before her departure—has fueled speculation, but official statements frame it as fulfilling her duties and advancing Trump’s policy priorities.
Gain-of-Function Research and Historical Controversies
Gain-of-function research refers to experiments that enhance the ability of viruses or bacteria to infect hosts or cause disease. It gained notoriety during debates over the COVID-19 pandemic origins, particularly regarding U.S. funding links to the Wuhan Institute of Virology in China.
Gabbard’s release echoes long-standing concerns about oversight, dual-use research (civilian programs with potential military applications), and biosafety lapses. The U.S. has funded such work globally for public health and threat reduction, but critics argue that insufficient transparency exists.
Geopolitical Ramifications: Echoes of Putin’s Claims?
Russia has long alleged U.S.-backed “biolabs” in Ukraine were developing biological weapons, using this as one narrative to justify its 2022 invasion. Putin and Russian officials cited threats from “weapons of mass destruction” programs.
The U.S., Ukraine, and international bodies have consistently described these facilities as public health and disease surveillance labs under Ukrainian control, part of cooperative threat reduction efforts—not weapons programs. Claims of bioweapons have been widely labeled as Russian disinformation.
Gabbard’s disclosure confirms U.S. funding and the presence of labs handling pathogens, but does not validate weapons development claims. It has nonetheless been seized upon by some as vindication for skepticism toward official narratives, while critics argue it recycles propaganda points.
This raises questions about whether the release bolsters Putin’s retrospective justifications—similar to U.S. actions in Iraq over alleged WMDs—or simply exposes legitimate transparency gaps under previous administrations. Gabbard has positioned it as stopping risky research that could endanger Americans and the world, including potential leaks from conflict zones.
Biological Weapons Convention and Global Norms
The 1972 Biological Weapons Convention (BWC), ratified by over 180 countries, including the U.S., prohibits the development, production, and stockpiling of biological weapons. It lacks robust verification mechanisms, leading to ongoing compliance debates.
The U.S. maintains that its programs are defensive and compliant. However, dual-use research and past incidents fuel distrust. Gabbard’s actions aim to increase scrutiny and end certain high-risk funding.
Reactions and Implications
Supporters view it as a win for accountability, aligning with Trump’s America First agenda and lessons from COVID.
Critics worry it undermines alliances, provides propaganda fodder for adversaries like Russia and China, and revives debunked conspiracy elements.
Ukraine has rejected the implications of illicit activity.
The disclosure directs the Intelligence Community to deepen collection on these facilities, identify pathogens, and support ending risky GoF work.
Broader Questions for Humanity
This episode highlights perennial tensions: balancing scientific advancement and biosecurity, government secrecy versus public trust, and the weaponization of narratives in geopolitics. As Gabbard exits public service for family reasons, her final act underscores unresolved debates over U.S. biological research programs that many Americans may have known little about.
Whether this promotes genuine reform or complicates international relations remains to be seen. The Trump administration has signaled continued focus on these issues.
